INTRODUCTION {#cesec10}
============

Bone repair is a highly complex regenerative process that includes interactions between a series of biological events, such as active gene synthesis and the action of a large number of cells and proteins, which will give rise to restoration of the integrity of the bone tissue[@bib1]. However, over the course of this process, changes culminating in regenerative deficiencies and consequent delayed consolidation and even bone nonunion may occur. It has been estimated that in the United States, out of the 6.2 million fractures that occur every year, around 10% evolve to non-consolidation and pseudarthrosis[@bib1].

Within this context, various biophysical and biochemical advances have been studied in an attempt to minimize the bone consolidation time and diminish the chances of possible complications stemming from the abnormal regeneration process[@bib2]. Among the topics studied have been the effects of treatments such as application of morphogenetic bone proteins, bioactive materials, use of low-intensity ultrasound (US) and use of low-level laser therapy (LLLT)[@bib3].

Bioactive materials or biomaterials are defined as materials that are capable of producing a specific biological response at the interface between the material and the tissue, thus forming a bond between them, without being toxic or promoting immunological responses[@bib4], [@bib5]. In the 1990s, our research group developed a highly bioactive glass ceramic with high-performance mechanical properties, named Biosilicate®[@bib6]. Some studies have been demonstrating the osteogenic potential of Biosilicate®, both *in vitro* and *in* vivo[@bib5], [@bib7].

In addition, LLLT and US have also been highlighted through their osteogenic potential. The effects from this therapy have been reported by several authors. Renno et al[@bib8] and Stein et al[@bib9] showed that there was a significant increase in osteoblast proliferation after irradiation with laser at 830 nm and 20 J/cm^2^. Moreover, the laser seemed to accelerate the fracture repair process and caused increases in callus volume and bone mineral density[@bib10]. Pinheiro et al[@bib11] showed that laser (830 nm, 40 mW, 4.8 J/cm^2^) was capable of increasing the quantity of mineralized bone tissue in fractures induced in the femurs of rats. US was found to have the effects of increasing cell proliferation and accelerating bone consolidation after a fracture, and increasing the mechanical strength of the bone callus in rats and rabbits[@bib12], [@bib13]. Takikawa et al[@bib12] observed in an experimental study that, after six weeks of US treatment, it had significantly increased the consolidation rate in fractures with bone nonunion, compared with the control group. The same results were found by Sun et al[@bib14] and Lirani et al[@bib15].

As stated above, biomaterials, US and LLLT have been emerging as promising alternatives for treating bone fractures. These resources not only present great osteogenic potential but also constitute noninvasive treatment methods and present relatively low cost. Studies investigating the effects from associating these resources in the consolidation process are scarce in the literature. Within this context, the present study had the aim of ascertaining the effects from associating Biosilicate® with US and LLLT in the bone consolidation process in rats, from biomechanical and histological analyses.

METHODOLOGY {#cesec20}
===========

Forty male Wistar rats weighing between 280 and 320 g were used in this study. The animals were kept under controlled environmental conditions (dark/light cycle of 12 hours each, cleaned environment, temperature of 24 ± 2 ^°^C and adequate ventilation), where they received ordinary feed and water *ad libitum.* This study was approved by the Ethics Committee for Animal Experimentation of the Federal University of São Carlos (Opinion Report 023/2006).

The animals were randomly distributed into four groups (n = 10): control group with fracture (FG): the rats in this group were subjected to a fracture but did not receive any treatment; Biosilicate® group (BG): the rats were subjected to a fracture and were treated with Biosilicate®; Biosilicate® + laser group (BLG): the rats were subjected to a fracture and were treated with an association of Biosilicate® + laser; Biosilicate® + US (BUSG): the rats were subjected to a fracture and were treated with an association of Biosilicate® + US.

To produce the bone defects, the rats were anesthetized in accordance with their body weight, using a mixture of ketamine and xylazine (80/10 mg/kg). After anesthesia, shaving and asepsis, an incision was made in both tibias. With the aid of a mini-drill fitted with a milling disc of 2.0 mm in diameter, irrigated with physiological serum, bone defects were made in the middle third of the tibia (10 mm below the knee joint). The procedure was completed by suturing the muscle and skin using monofilament 4.0 nylon thread, with a distance of 1 cm between the stitches, and cleaning the site. The animals continued to be provided with free access to water and food until the time of sacrifice.

TREATMENTS {#cesec30}
==========

Biomaterial {#cesec40}
-----------

The bioactive material used was Biosilicate^®^. This is a highly bioactive glass ceramic composed of the chemical elements silicon, oxygen, sodium, calcium and phosphorus (Si, O, Na, Ca and P), which are released into solution in the form of Si(OH)~4~, Na+, Ca^2+^ and PO~4~^2-^. Biosilicate® was used in this study in granulated form, with grain size of approximately 180-212 μm. This was introduced into the defect by means of an appropriate spatula, just after the defect was made, and the circular fracture was completely filled. The details of the composition of Biosilicate® and the thermal treatment are described in the patent WO 2004/074199.

Low-level laser {#cesec50}
---------------

The device used was a portable DMC laser: THERALASE version 24, class 3B, Ga-Al-As diode, with a wavelength of 830 nm, continuous emission, output power of 100 mW, power density of 3.57 W/cm^2^, beam area of 0.028 cm^2^ and divergence of 1.5°. The application was made at just one point, with a fluence of 120 J/cm2, for 34 seconds, thereby supplying 3.4 J of energy.

Low-intensity ultrasound {#cesec60}
------------------------

A portable ultrasound device was used (Exogen, United States), in pulsed mode with a burst of 1.5 MHz, pulse width of 200 us, pulse repetition frequency of 1 kHz and intensity of 30 mW/cm^2^, for 20 minutes.

The treatments started immediately after the operative procedure, with subsequent applications on the 2^nd^, 4^th^, 6^th^, 8^th^, 10^th^ and 12^th^ days after the operation, thus totaling seven applications in 14 days.

On the 14^th^ day after the experimental procedure, the animals were sacrificed by means of a lethal dose of anesthesia, injected intraperitoneally. The tibias were then extracted and the soft tissue was removed for subsequent analyses.

Biomechanical analysis {#cesec70}
----------------------

The biomechanical analysis was done by means of the three-point flexion test. The test was done on the animals' right tibia in all the groups. The biomechanical tests were performed on the Instron universal testing machine (model 4444), at room temperature. To carry out the tests, a load cell of maximum capacity 1 kN and a preload of 5 N were used. A metal support of 3.8 cm in length was used, thus exposing only 1.8 cm of the test body. The tibias were positioned with the defect region on the underside, such that this region would be subjected to traction. From this test, the following variables were obtained: maximum load (kN), resilience (J) and tenacity (J).

Histological analysis {#cesec80}
---------------------

The tibias were subjected to decalcification in MORSE decalcifying solution (20% sodium citrate and 50% formic acid in equal parts) and were then processed in paraffin. The paraffin blocks were cut longitudinally into slices of standardized thickness 5.0 μm and histological slides were produced. The sections were then stained with hematoxylin and eosin (HE) for qualitative analysis, and with Masson\'s trichrome (MT) for morphometry. Each animal was represented by two histological slides, each containing a series of at least three consecutive slices.

The histopathological analysis was carried out using an optical microscope (Olympus, Optical Co. Ltd, Tokyo, Japan). Modifications such as the presence of neoformed bone, medullary tissue, presence of inflammatory infiltrate and granulation tissue were taken into consideration.

The morphometry of the neoformed bone area in the region of each animal\'s defect was measured using the Motican 5.0 image analysis system. The slides were observed in two areas of the cortical region of the defect. The two areas were selected and named C1 and C2, corresponding to the upper and lower cortical areas of the defect. The neoformed bone tissue present in these regions was measured and the area seen in the 10X objective lens was registered. After this, the areas were summed, thus resulting in the total area of neoformed tissue in the defect.

STATISTICAL ANALYSIS {#cesec90}
====================

The data were analyzed statistically using descriptive techniques such as tables and graphs, in the form of means and standard deviations. The Shapiro-Wilk W test was used on all the variables to ascertain whether they presented normal distribution. If the distribution was normal, comparisons were made using one-way ANOVA with the post-hoc Tukey-HSD test. If the distribution was not normal, the Kruskal-Wallis test was used. The analyses were performed using the Statistica software, version 7.0. The significance level was taken to be p ≤ 0.05.

RESULTS {#cesec100}
=======

Biomechanical analysis {#cesec110}
----------------------

[Table 1](#tbl1){ref-type="table"} presents the means and standard deviations of the mechanical properties of all the experimental groups. The statistical analysis did not demonstrate any significant differences between any of the groups after the experimental period of 14 days.

Qualitative histological analysis {#cesec120}
---------------------------------

It can be seen from [Figure 1A](#fig1){ref-type="fig"} that the control group had moderate presence of neoformed bone tissue inside the defects and moderate presence of inflammatory infiltrate. The animals treated only with Biosilicate® presented histopathological findings similar to those of the animals in the control group, with a moderate quantity of neoformed bone tissue ([Figure 1B](#fig1){ref-type="fig"}). Nonetheless, the osteogenic potential of the biomaterial was seen, given that there was great presence of cells and bone tissue around the particles. Interestingly, the groups with Biosilicate® in association with therapeutic laser and with US demonstrated some presence of cellular infiltrate, but with smaller amounts of neoformed bone tissue deposition than in the control group and the group with Biosilicate® alone ([Figures 1C and 1D](#fig1){ref-type="fig"}).

Morphometric analysis {#cesec130}
---------------------

It can be seen in [Figure 2](#fig2){ref-type="fig"} that the groups treated with the associations of Biosilicate® + laser and Biosilicate® + US presented significantly smaller quantities of neoformed bone tissue area than shown by the untreated control group and the group treated only with Biosilicate®. However, no difference was found between these groups.

DISCUSSION {#cesec140}
==========

Use of biomaterials for bone repair has grown considerably over recent years[@bib16]. The present study showed the osteogenic potential of Biosilicate®, given that it was possible to see the deposition of neoformed bone tissue around the biomaterial particles. However, the quantity of bone tissue was no greater than in the control group, possibly because of the short experimental period used in this study. Moreover, no modifications to the biomechanical properties were observed.

In the present study, we used a highly bioactive glass ceramic material called Biosilicate®. It has been reported in the literature that when a bioactive material comes into contact with body fluids, a layer of hydroxycarbonate apatite is formed on the surface, thus promoting osteogenesis[@bib17]. Previous studies (both *in vivo* and *in vitro*) have demonstrated that Biosilicate® has high osteogenic potential. Moura et al[@bib5] showed that Biosilicate® can induce bone tissue formation in a culturing system for osteoblastic cells. In an *in viv*o study, Granito et al[@bib7] observed that there was greater bone formation in defects filled with Biosilicate® than in those filled with bioglass 45S5^®^, which is currently considered to be the gold standard for bioactive materials.

Following the positive results from Biosilicate® in the bone repair process, a hypothesis that the effect from this material could be boosted through laser irradiation and/or ultrasound energy was raised. However, the results from the present study demonstrated that the animals whose bone defects were filled with Biosilicate® also received LLLT and US therapy presented a significant decrease in the quantity of neoformed bone tissue, compared with the control group.

The mechanism through which this occurs is unclear. It is known that Biosilicate® is a highly bioactive glass ceramic[@bib5] and that both LLLT and US have high osteogenic potential[@bib11], [@bib18]. One hypothesis may be that associating these types of treatment might have caused excessive stimulation to the lesion site. In addition, parameters like power, wavelength and fluence may have influenced this process and may have inhibited cell migration and growth on the surface of the glass ceramic.

Similar results were found by Rennó et al[@bib19], who conducted an *in vitro* evaluation on the effects of laser therapy at 830 nm and 10 J/cm^2^ on the proliferation of osteoblastic cells on Biosilicate® scaffolds. It was demonstrated that MC3T3 cells grew successfully on scaffolds composed of Biosilicato®, with osteoblast cells presenting normal morphology and easily adhering and proliferating by means of the disc surfaces. On the other hand, laser irradiation produced a 13% decrease in osteoblast proliferation (MC3T3) in the Biosilicate® discs.

Some resent studies have reported that there is an increase in osseointegration between bone tissue and implants subsequent to laser and US. In a study assessing the effects of LLLT on hydroxyapatite implants, satisfactory results were found. LLLT using GaAsAl at 780 nm was found to promote a greater degree of osseointegration at the bone-hydroxyapatite interface, thus suggesting that LLLT may be considered to be a good tool for boosting the bone-implant interface in orthopedic surgery[@bib20]. AboElsaad et al[@bib21] evaluated the effects of LLLT using 830 nm and bioactive glass implants in periodontal defects. The results showed that LLLT in association with biomaterial had a positive effect with regard to accelerating the periodontal repair. In a study evaluating the action of US on bone growth in hydroxyapatite implants, Iwai et al[@bib22] found positive results from US associated with the biomaterial. US was capable of increasing the number of osteoblasts and the quantity of bone in hydroxyapatite implants.

CONCLUSION {#cesec150}
==========

Based on the results from this study, we can conclude that Biosilicate® was capable of accelerating and boosting bone recovery, through modulating the inflammatory process and stimulating new bone tissue formation. However, when LLLT or US were used in association, no positive results were found.

Work carried out at the Universidade Federal de São Carlos - SP.

**The authors declare that there was no conflict of interest in conducting this work**

**This article is available online in Portuguese and English at the websites:**[**www.rbo.org.br**](http://www.rbo.org.br){#interrefs10}**and**[**www.scielo.br/rbort**](http://www.scielo.br/rbort){#interrefs20}

![Photomicrograph of the morphological findings from the different experimental groups. In the region of the defect, granulation tissue (arrows) and neoformed tissue (\*) can be observed, and in the respective groups, the presence of the biomaterial (B). (A) FG; fracture control; (B) BG; Biosilicate®; (C) BUSG: Biosilicate® + ultrasound; (D) BLG; Biosilicate® + laser. Staining: H.E.](gr1){#fig1}

![Means and standard deviations of the area neoformed bone of the different experimental groups. a p \< 0.05 vs FG; \* p \< 0.05 vs BG. FG: fracture control; BG; Biosilicate® ; BLG; Biosilicate® + laser; BUSG: Biosilicate® + ultrasound.](gr2){#fig2}

###### 

Biomechanical properties of the tibias of the experimental groups (mean ± SD).

  Group   Maximum load (kN)   Tenacity (J)    Resilience (J)
  ------- ------------------- --------------- ----------------
  FG      0.064 ± 0.020       0.057 ± 0.011   0.029 ± 0.012
                                              
  BG      0.063 ± 0.014       0.069 ± 0.018   0.033 ± 0.010
                                              
  BUSG    0.053 ± 0.012       0.049 ± 0.018   0.027 ± 0.010
                                              
  BLG     0.049 ± 0.014       0.057 ± 0.020   0.028 ± 0.007

FG: fracture control; BG; Biosilicate®; BUSG: Biosilicate® + ultrasound; BLG; Biosilicate® + laser.
